| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/20/2000 | DE19901692A1 Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes A process for the production of pellets with a content of up to 90% of a pharmaceutical active ingredient by weight. |
| 07/20/2000 | DE19901687A1 Opioide Analgetika mit kontrollierter Wirkstofffreisetzung Opioid analgesics controlled release |
| 07/20/2000 | DE19901686A1 Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung Retarded tramadol with a storage-stable release profile and methods for their preparation |
| 07/20/2000 | DE19901683A1 Analgetikum mit kontrollierter Wirkstofffreisetzung Analgesic with controlled release of active ingredient |
| 07/20/2000 | DE19901040A1 Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe Controlled release dosage forms containing highly water-soluble drugs |
| 07/20/2000 | CA2724287A1 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2360358A1 Compositions having improved stability |
| 07/20/2000 | CA2360346A1 Improved microbial preparations |
| 07/20/2000 | CA2360243A1 Use of lactobacillus salivarius |
| 07/20/2000 | CA2360227A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 07/20/2000 | CA2359474A1 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | CA2359381A1 Medicament forms having controlled release and containing active substances which easily dissolve in water |
| 07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | CA2359345A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | CA2359273A1 Pharmaceutical formulations containing an opioid and an .alpha.-agonist |
| 07/20/2000 | CA2358662A1 Therapeutic compositions for metabolic bone disorders or bone metastases |
| 07/20/2000 | CA2358638A1 Composition and methods for administration of water-insoluble paclitaxel derivatives |
| 07/20/2000 | CA2356944A1 Compositions having improved stability |
| 07/20/2000 | CA2356776A1 Transcutaneous photodynamic treatment of targeted cells |
| 07/20/2000 | CA2356706A1 Novel exendin agonist formulations and methods of administration thereof |
| 07/19/2000 | EP1020494A1 Entrapment of vitamines with an elastomeric silicone polyether |
| 07/19/2000 | EP1020193A1 Oral preparation |
| 07/19/2000 | EP1020186A2 Sustained release tramadol preparations with a storage stable release profile and process for their manufacture |
| 07/19/2000 | EP1020185A2 Opioid analgesics with controlled release |
| 07/19/2000 | EP1020183A2 Analgesic composition with controlled release |
| 07/19/2000 | EP1020181A1 Process for producing pellets with a pharmaceutical agent content of up to 90% w/w |
| 07/19/2000 | EP1019446A1 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 07/19/2000 | EP1019438A1 Apoptosis-related compounds and their use |
| 07/19/2000 | EP1019437A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 07/19/2000 | EP1019417A1 Phospholipid analogue compounds |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019365A1 Novel compositions for the delivery of negatively charged molecules |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019096A2 Bioresorbable compositions for implantable prostheses |
| 07/19/2000 | EP1019090A1 Polymeric derivatives of camptothecins |
| 07/19/2000 | EP1019089A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019073A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019061A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/19/2000 | EP1019058A1 Pharmaceutical suspension comprising nevirapine hemihydrate |
| 07/19/2000 | EP1019053A1 Amorphous paroxetine composition |
| 07/19/2000 | EP1019039A1 Compressed nitroglycerin tablet and its method of manufacture |
| 07/19/2000 | EP1019037A1 Medicament containing delta-aminolevulinic acid |
| 07/19/2000 | EP1019034A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/19/2000 | EP1019031A1 Biodegradable macromers for the controlled release of biologically active substances |
| 07/19/2000 | EP1019030A1 Method for making a multi-stage drug delivery system |
| 07/19/2000 | EP1019027A1 Implantable collagen-containing putty material |
| 07/19/2000 | EP1019025A1 Peptide/lipid complex formation by co-lyophilization |
| 07/19/2000 | EP1019023A1 Stabilized preparations for use in nebulizers |
| 07/19/2000 | EP1019022A1 Perforated microparticles and methods of use |
| 07/19/2000 | EP1019021A1 Stabilized preparations for use in metered dose inhalers |
| 07/19/2000 | EP1019020A1 Stabilized bioactive preparations and methods of use |
| 07/19/2000 | EP1019016A1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 07/19/2000 | EP1019010A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1018880A1 2-methyl-thieno-benzodiazepine formulation |
| 07/19/2000 | EP0777495B1 Stable, aqueous alfa interferon solution formulations |
| 07/19/2000 | EP0756493B1 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base |
| 07/19/2000 | EP0661966B1 Ulcer prevention and treatment composition and method |
| 07/19/2000 | EP0389570B2 High integrity liposomes and method of preration and use |
| 07/19/2000 | CN1260725A Conjugate composing folic acid antagonist and carrier |
| 07/19/2000 | CN1260718A Antithelmintic compositions |
| 07/19/2000 | CN1260714A Controlled release pharmaceutical preparation with ACE inhibitor as active agent |
| 07/19/2000 | CN1260713A Proliposome powders for inhalation stabilised by tocopherol |
| 07/19/2000 | CN1260171A Recombined alpha-type interferon freeze-drying protective agent |
| 07/19/2000 | CN1054543C Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 07/19/2000 | CN1054510C Stable solution of rebeccamycin analog and preparation thereof |
| 07/19/2000 | CN1054507C Preparation method for medicinal composition for treatment of vaginal infections |
| 07/19/2000 | CN1054506C Pharmaceutical composition use |
| 07/18/2000 | US6090958 N-(8-carboxyoctyl)-o-hydroxybenzamide and salts |
| 07/18/2000 | US6090947 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 07/18/2000 | US6090938 Detection of modulators of gene expression: for measurement of glucans in fluids; for treatment of infections, inflammation, autoimmune diseases, ischemia, cancer, and asthma; anticarcinogenic agents; antiischemic agents |
| 07/18/2000 | US6090925 Macromolecular microparticles and methods of production and use |
| 07/18/2000 | US6090924 Human-Human CLNH5-specific antibodies |
| 07/18/2000 | US6090915 Collagen or gelatin crumble composition and uses |
| 07/18/2000 | US6090827 Pharmaceutical formulation of omeprazole |
| 07/18/2000 | US6090793 Non-mitogenic substance, its preparation and use |
| 07/18/2000 | US6090784 RNA polymerase II peptides and methods of use |
| 07/18/2000 | US6090411 Monolithic tablet for controlled drug release |
| 07/18/2000 | US6090410 Dry mix formulation for bisphosphonic acids |
| 07/18/2000 | US6090405 Multilayer; backing layer and pressure sensitive adhesive |
| 07/18/2000 | US6090404 Sustained release patch |
| 07/18/2000 | US6090401 Stable foam composition |
| 07/18/2000 | US6090395 Skin antiseptics; alcohol and chlorhexidine digluconate, with thickener |
| 07/18/2000 | US6090381 Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope |
| 07/18/2000 | US6090368 Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine |
| 07/18/2000 | US6090317 Polyoxyethylene having a sugar on one end and a different functional group on the other end and a method of production thereof |
| 07/18/2000 | US6089234 Method for destroying residual lens epithelial cells |
| 07/18/2000 | CA2295790A1 Controlled release tramadol preparations having a storage-stable table release profile and process for the production thereof |
| 07/18/2000 | CA2295471A1 Opioid analgesics with controlled active substance release |
| 07/18/2000 | CA2295470A1 Process for the preparation of pellets with a content of up to 90 wt.% of a pharmaceutical active ingredient |
| 07/18/2000 | CA2295469A1 Analgesic with controlled active substance release |
| 07/18/2000 | CA2202707C Non-aqueous oral-drench compositions containing avermectin compounds |
| 07/18/2000 | CA2162689C Immunotoxins comprising gelonin and an antibody |
| 07/18/2000 | CA2129051C Absorbable composite materials for use in the treatment of periodontal disease |
| 07/18/2000 | CA2087087C Molecules for iontophoretic delivery |
| 07/18/2000 | CA2044398C Programmed release oral solid pharmaceutical dosage form |
| 07/18/2000 | CA2014633C Stable anhydrous compositions for topical delivery of active materials |
| 07/18/2000 | CA2008183C Liquid pharmaceutical composition for piperidinoalkanol derivatives |